The VIrtual coordinating center for Global cOllaborative cardiovascUlar Research (VIGOUR) is a global network of coordinating centers and investigators experienced in the conduct of large cardiovascular clinical trials.

It arose from a collaboration of investigators participating in the international Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial, a 41,000-patient study that began in 1990. The group's reach now extends to main coordinating centers in North and South America, Europe, and Australasia. Such a network ensures that even global trials can receive the benefits of experienced local leadership.